First modification: Last modification:
–
Brasilia (AFP) – The pharmaceutical company Pfizer requested this Friday to the National Sanitary Surveillance Agency (Anvisa) of Brazil to authorize the use of its anti-coronavirus vaccine for infants between 5 and 11 years old, the Brazilian institution reported.
Anvisa “received a request from Pfizer to include the age group from 5 to 11 years in the indication of its Comirnaty vaccine,” it said in a statement.
Pfizer’s order indicates that the dosage of the vaccine “will be adjusted and lower than that used for those over 12 years of age” and will be distributed in different packages, Anvisa said.
Pfizer, for its part, indicated in a note that, according to a “preliminary analysis”, “a regimen of two doses of 10 micrograms of the vaccine was shown to be safe and capable of generating a high level of antibodies” in this age group.